London: The finding that women who received early chemotherapy for a recurrence of ovarian cancer did not live longer than those whose treatment is delayed needs to be reviewed, says an expert.
Rahul Gandhi addresses FICCI meet
Is AAP afraid to form a govt?
Adarsh scam: A tale of greed and nepotism?
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi